Global Gastrointestinal Stromal Tumor Treatment Market Research Report 2026

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Stromal Tumor Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Drugs
1.2.3 Surgery Equipment
1.2.4 Others
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumor Treatment Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor Treatment Market Perspective (2021–2032)
2.2 Global Gastrointestinal Stromal Tumor Treatment Growth Trends by Region
2.2.1 Global Gastrointestinal Stromal Tumor Treatment Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Gastrointestinal Stromal Tumor Treatment Historic Market Size by Region (2021–2026)
2.2.3 Gastrointestinal Stromal Tumor Treatment Forecasted Market Size by Region (2027–2032)
2.3 Gastrointestinal Stromal Tumor Treatment Market Dynamics
2.3.1 Gastrointestinal Stromal Tumor Treatment Industry Trends
2.3.2 Gastrointestinal Stromal Tumor Treatment Market Drivers
2.3.3 Gastrointestinal Stromal Tumor Treatment Market Challenges
2.3.4 Gastrointestinal Stromal Tumor Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Stromal Tumor Treatment Players by Revenue
3.1.1 Global Top Gastrointestinal Stromal Tumor Treatment Players by Revenue (2021–2026)
3.1.2 Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Players (2021–2026)
3.2 Global Top Gastrointestinal Stromal Tumor Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Gastrointestinal Stromal Tumor Treatment Revenue
3.4 Global Gastrointestinal Stromal Tumor Treatment Market Concentration Ratio
3.4.1 Global Gastrointestinal Stromal Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Treatment Revenue in 2025
3.5 Global Key Players of Gastrointestinal Stromal Tumor Treatment Head Offices and Areas Served
3.6 Global Key Players of Gastrointestinal Stromal Tumor Treatment, Products and Applications
3.7 Global Key Players of Gastrointestinal Stromal Tumor Treatment, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Gastrointestinal Stromal Tumor Treatment Breakdown Data by Type
4.1 Global Gastrointestinal Stromal Tumor Treatment Historic Market Size by Type (2021–2026)
4.2 Global Gastrointestinal Stromal Tumor Treatment Forecasted Market Size by Type (2027–2032)
5 Gastrointestinal Stromal Tumor Treatment Breakdown Data by Application
5.1 Global Gastrointestinal Stromal Tumor Treatment Historic Market Size by Application (2021–2026)
5.2 Global Gastrointestinal Stromal Tumor Treatment Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Gastrointestinal Stromal Tumor Treatment Market Size (2021–2032)
6.2 North America Gastrointestinal Stromal Tumor Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Gastrointestinal Stromal Tumor Treatment Market Size by Country (2021–2026)
6.4 North America Gastrointestinal Stromal Tumor Treatment Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Stromal Tumor Treatment Market Size (2021–2032)
7.2 Europe Gastrointestinal Stromal Tumor Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Gastrointestinal Stromal Tumor Treatment Market Size by Country (2021–2026)
7.4 Europe Gastrointestinal Stromal Tumor Treatment Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Stromal Tumor Treatment Market Size (2021–2032)
8.2 Asia-Pacific Gastrointestinal Stromal Tumor Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Gastrointestinal Stromal Tumor Treatment Market Size by Region (2021–2026)
8.4 Asia-Pacific Gastrointestinal Stromal Tumor Treatment Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Gastrointestinal Stromal Tumor Treatment Market Size (2021–2032)
9.2 Latin America Gastrointestinal Stromal Tumor Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Gastrointestinal Stromal Tumor Treatment Market Size by Country (2021–2026)
9.4 Latin America Gastrointestinal Stromal Tumor Treatment Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size (2021–2032)
10.2 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Country (2021–2026)
10.4 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 B. Braun Melsungen
11.1.1 B. Braun Melsungen Company Details
11.1.2 B. Braun Melsungen Business Overview
11.1.3 B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Introduction
11.1.4 B. Braun Melsungen Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.1.5 B. Braun Melsungen Recent Development
11.2 Aohua Endoscopy
11.2.1 Aohua Endoscopy Company Details
11.2.2 Aohua Endoscopy Business Overview
11.2.3 Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Introduction
11.2.4 Aohua Endoscopy Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.2.5 Aohua Endoscopy Recent Development
11.3 Olympus
11.3.1 Olympus Company Details
11.3.2 Olympus Business Overview
11.3.3 Olympus Gastrointestinal Stromal Tumor Treatment Introduction
11.3.4 Olympus Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.3.5 Olympus Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Gastrointestinal Stromal Tumor Treatment Introduction
11.4.4 Novartis Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.4.5 Novartis Recent Development
11.5 Bayer Pharmaceuticals
11.5.1 Bayer Pharmaceuticals Company Details
11.5.2 Bayer Pharmaceuticals Business Overview
11.5.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Introduction
11.5.4 Bayer Pharmaceuticals Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.5.5 Bayer Pharmaceuticals Recent Development
11.6 Glenmark Pharmaceuticals Ltd.
11.6.1 Glenmark Pharmaceuticals Ltd. Company Details
11.6.2 Glenmark Pharmaceuticals Ltd. Business Overview
11.6.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Introduction
11.6.4 Glenmark Pharmaceuticals Ltd. Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.6.5 Glenmark Pharmaceuticals Ltd. Recent Development
11.7 Fortimedix Surgical
11.7.1 Fortimedix Surgical Company Details
11.7.2 Fortimedix Surgical Business Overview
11.7.3 Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Introduction
11.7.4 Fortimedix Surgical Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.7.5 Fortimedix Surgical Recent Development
11.8 Cook Medical
11.8.1 Cook Medical Company Details
11.8.2 Cook Medical Business Overview
11.8.3 Cook Medical Gastrointestinal Stromal Tumor Treatment Introduction
11.8.4 Cook Medical Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.8.5 Cook Medical Recent Development
11.9 Actavis Generics
11.9.1 Actavis Generics Company Details
11.9.2 Actavis Generics Business Overview
11.9.3 Actavis Generics Gastrointestinal Stromal Tumor Treatment Introduction
11.9.4 Actavis Generics Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.9.5 Actavis Generics Recent Development
11.10 Dr. Reddy's Laboratories
11.10.1 Dr. Reddy's Laboratories Company Details
11.10.2 Dr. Reddy's Laboratories Business Overview
11.10.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Introduction
11.10.4 Dr. Reddy's Laboratories Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.10.5 Dr. Reddy's Laboratories Recent Development
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Teva Pharmaceutical Industries Ltd. Company Details
11.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Introduction
11.11.4 Teva Pharmaceutical Industries Ltd. Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.11.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.12 Sonoscape
11.12.1 Sonoscape Company Details
11.12.2 Sonoscape Business Overview
11.12.3 Sonoscape Gastrointestinal Stromal Tumor Treatment Introduction
11.12.4 Sonoscape Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.12.5 Sonoscape Recent Development
11.13 Huger endoscopy instruments
11.13.1 Huger endoscopy instruments Company Details
11.13.2 Huger endoscopy instruments Business Overview
11.13.3 Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Introduction
11.13.4 Huger endoscopy instruments Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.13.5 Huger endoscopy instruments Recent Development
11.14 Bulat Pharmaceutical
11.14.1 Bulat Pharmaceutical Company Details
11.14.2 Bulat Pharmaceutical Business Overview
11.14.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Introduction
11.14.4 Bulat Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.14.5 Bulat Pharmaceutical Recent Development
11.15 MSN Laboratories
11.15.1 MSN Laboratories Company Details
11.15.2 MSN Laboratories Business Overview
11.15.3 MSN Laboratories Gastrointestinal Stromal Tumor Treatment Introduction
11.15.4 MSN Laboratories Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.15.5 MSN Laboratories Recent Development
11.16 Apotex Inc.
11.16.1 Apotex Inc. Company Details
11.16.2 Apotex Inc. Business Overview
11.16.3 Apotex Inc. Gastrointestinal Stromal Tumor Treatment Introduction
11.16.4 Apotex Inc. Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.16.5 Apotex Inc. Recent Development
11.17 Boston Scientific
11.17.1 Boston Scientific Company Details
11.17.2 Boston Scientific Business Overview
11.17.3 Boston Scientific Gastrointestinal Stromal Tumor Treatment Introduction
11.17.4 Boston Scientific Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.17.5 Boston Scientific Recent Development
11.18 Arthrex
11.18.1 Arthrex Company Details
11.18.2 Arthrex Business Overview
11.18.3 Arthrex Gastrointestinal Stromal Tumor Treatment Introduction
11.18.4 Arthrex Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.18.5 Arthrex Recent Development
11.19 Johnson & Johnson
11.19.1 Johnson & Johnson Company Details
11.19.2 Johnson & Johnson Business Overview
11.19.3 Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Introduction
11.19.4 Johnson & Johnson Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.19.5 Johnson & Johnson Recent Development
11.20 CSPC Pharmaceuticals
11.20.1 CSPC Pharmaceuticals Company Details
11.20.2 CSPC Pharmaceuticals Business Overview
11.20.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Introduction
11.20.4 CSPC Pharmaceuticals Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.20.5 CSPC Pharmaceuticals Recent Development
11.21 Hansoh Pharmaceuticals
11.21.1 Hansoh Pharmaceuticals Company Details
11.21.2 Hansoh Pharmaceuticals Business Overview
11.21.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Introduction
11.21.4 Hansoh Pharmaceuticals Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.21.5 Hansoh Pharmaceuticals Recent Development
11.22 Kelun Pharmaceuticals
11.22.1 Kelun Pharmaceuticals Company Details
11.22.2 Kelun Pharmaceuticals Business Overview
11.22.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Introduction
11.22.4 Kelun Pharmaceuticals Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.22.5 Kelun Pharmaceuticals Recent Development
11.23 Zai Lab
11.23.1 Zai Lab Company Details
11.23.2 Zai Lab Business Overview
11.23.3 Zai Lab Gastrointestinal Stromal Tumor Treatment Introduction
11.23.4 Zai Lab Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.23.5 Zai Lab Recent Development
11.24 CStone Pharmaceuticals
11.24.1 CStone Pharmaceuticals Company Details
11.24.2 CStone Pharmaceuticals Business Overview
11.24.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Introduction
11.24.4 CStone Pharmaceuticals Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.24.5 CStone Pharmaceuticals Recent Development
11.25 China Biopharmaceuticals
11.25.1 China Biopharmaceuticals Company Details
11.25.2 China Biopharmaceuticals Business Overview
11.25.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Introduction
11.25.4 China Biopharmaceuticals Revenue in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
11.25.5 China Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Gastrointestinal Stromal Tumor Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Drugs
Table 3. Key Players of Surgery Equipment
Table 4. Key Players of Others
Table 5. Global Gastrointestinal Stromal Tumor Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Gastrointestinal Stromal Tumor Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Gastrointestinal Stromal Tumor Treatment Market Size by Region (US$ Million), 2021–2026
Table 8. Global Gastrointestinal Stromal Tumor Treatment Market Share by Region (2021–2026)
Table 9. Global Gastrointestinal Stromal Tumor Treatment Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Gastrointestinal Stromal Tumor Treatment Market Share by Region (2027–2032)
Table 11. Gastrointestinal Stromal Tumor Treatment Market Trends
Table 12. Gastrointestinal Stromal Tumor Treatment Market Drivers
Table 13. Gastrointestinal Stromal Tumor Treatment Market Challenges
Table 14. Gastrointestinal Stromal Tumor Treatment Market Restraints
Table 15. Global Gastrointestinal Stromal Tumor Treatment Revenue by Players (US$ Million), 2021–2026
Table 16. Global Gastrointestinal Stromal Tumor Treatment Market Share by Players (2021–2026)
Table 17. Global Top Gastrointestinal Stromal Tumor Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gastrointestinal Stromal Tumor Treatment Revenue, 2025
Table 18. Ranking of Global Top Gastrointestinal Stromal Tumor Treatment Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumor Treatment Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Gastrointestinal Stromal Tumor Treatment, Headquarters and Area Served
Table 21. Global Key Players of Gastrointestinal Stromal Tumor Treatment, Products and Applications
Table 22. Global Key Players of Gastrointestinal Stromal Tumor Treatment, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Gastrointestinal Stromal Tumor Treatment Market Size by Type (US$ Million), 2021–2026
Table 25. Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Type (2021–2026)
Table 26. Global Gastrointestinal Stromal Tumor Treatment Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Type (2027–2032)
Table 28. Global Gastrointestinal Stromal Tumor Treatment Market Size by Application (US$ Million), 2021–2026
Table 29. Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Application (2021–2026)
Table 30. Global Gastrointestinal Stromal Tumor Treatment Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Gastrointestinal Stromal Tumor Treatment Revenue Market Share by Application (2027–2032)
Table 32. North America Gastrointestinal Stromal Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Gastrointestinal Stromal Tumor Treatment Market Size by Country (US$ Million), 2021–2026
Table 34. North America Gastrointestinal Stromal Tumor Treatment Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Gastrointestinal Stromal Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Gastrointestinal Stromal Tumor Treatment Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Gastrointestinal Stromal Tumor Treatment Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Gastrointestinal Stromal Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Gastrointestinal Stromal Tumor Treatment Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Gastrointestinal Stromal Tumor Treatment Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Country (US$ Million), 2027–2032
Table 47. B. Braun Melsungen Company Details
Table 48. B. Braun Melsungen Business Overview
Table 49. B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Product
Table 50. B. Braun Melsungen Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 51. B. Braun Melsungen Recent Development
Table 52. Aohua Endoscopy Company Details
Table 53. Aohua Endoscopy Business Overview
Table 54. Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Product
Table 55. Aohua Endoscopy Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 56. Aohua Endoscopy Recent Development
Table 57. Olympus Company Details
Table 58. Olympus Business Overview
Table 59. Olympus Gastrointestinal Stromal Tumor Treatment Product
Table 60. Olympus Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 61. Olympus Recent Development
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Gastrointestinal Stromal Tumor Treatment Product
Table 65. Novartis Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 66. Novartis Recent Development
Table 67. Bayer Pharmaceuticals Company Details
Table 68. Bayer Pharmaceuticals Business Overview
Table 69. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product
Table 70. Bayer Pharmaceuticals Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 71. Bayer Pharmaceuticals Recent Development
Table 72. Glenmark Pharmaceuticals Ltd. Company Details
Table 73. Glenmark Pharmaceuticals Ltd. Business Overview
Table 74. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Product
Table 75. Glenmark Pharmaceuticals Ltd. Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 76. Glenmark Pharmaceuticals Ltd. Recent Development
Table 77. Fortimedix Surgical Company Details
Table 78. Fortimedix Surgical Business Overview
Table 79. Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Product
Table 80. Fortimedix Surgical Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 81. Fortimedix Surgical Recent Development
Table 82. Cook Medical Company Details
Table 83. Cook Medical Business Overview
Table 84. Cook Medical Gastrointestinal Stromal Tumor Treatment Product
Table 85. Cook Medical Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 86. Cook Medical Recent Development
Table 87. Actavis Generics Company Details
Table 88. Actavis Generics Business Overview
Table 89. Actavis Generics Gastrointestinal Stromal Tumor Treatment Product
Table 90. Actavis Generics Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 91. Actavis Generics Recent Development
Table 92. Dr. Reddy's Laboratories Company Details
Table 93. Dr. Reddy's Laboratories Business Overview
Table 94. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Product
Table 95. Dr. Reddy's Laboratories Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 96. Dr. Reddy's Laboratories Recent Development
Table 97. Teva Pharmaceutical Industries Ltd. Company Details
Table 98. Teva Pharmaceutical Industries Ltd. Business Overview
Table 99. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Product
Table 100. Teva Pharmaceutical Industries Ltd. Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 101. Teva Pharmaceutical Industries Ltd. Recent Development
Table 102. Sonoscape Company Details
Table 103. Sonoscape Business Overview
Table 104. Sonoscape Gastrointestinal Stromal Tumor Treatment Product
Table 105. Sonoscape Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 106. Sonoscape Recent Development
Table 107. Huger endoscopy instruments Company Details
Table 108. Huger endoscopy instruments Business Overview
Table 109. Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Product
Table 110. Huger endoscopy instruments Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 111. Huger endoscopy instruments Recent Development
Table 112. Bulat Pharmaceutical Company Details
Table 113. Bulat Pharmaceutical Business Overview
Table 114. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Product
Table 115. Bulat Pharmaceutical Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 116. Bulat Pharmaceutical Recent Development
Table 117. MSN Laboratories Company Details
Table 118. MSN Laboratories Business Overview
Table 119. MSN Laboratories Gastrointestinal Stromal Tumor Treatment Product
Table 120. MSN Laboratories Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 121. MSN Laboratories Recent Development
Table 122. Apotex Inc. Company Details
Table 123. Apotex Inc. Business Overview
Table 124. Apotex Inc. Gastrointestinal Stromal Tumor Treatment Product
Table 125. Apotex Inc. Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 126. Apotex Inc. Recent Development
Table 127. Boston Scientific Company Details
Table 128. Boston Scientific Business Overview
Table 129. Boston Scientific Gastrointestinal Stromal Tumor Treatment Product
Table 130. Boston Scientific Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 131. Boston Scientific Recent Development
Table 132. Arthrex Company Details
Table 133. Arthrex Business Overview
Table 134. Arthrex Gastrointestinal Stromal Tumor Treatment Product
Table 135. Arthrex Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 136. Arthrex Recent Development
Table 137. Johnson & Johnson Company Details
Table 138. Johnson & Johnson Business Overview
Table 139. Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Product
Table 140. Johnson & Johnson Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 141. Johnson & Johnson Recent Development
Table 142. CSPC Pharmaceuticals Company Details
Table 143. CSPC Pharmaceuticals Business Overview
Table 144. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product
Table 145. CSPC Pharmaceuticals Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 146. CSPC Pharmaceuticals Recent Development
Table 147. Hansoh Pharmaceuticals Company Details
Table 148. Hansoh Pharmaceuticals Business Overview
Table 149. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product
Table 150. Hansoh Pharmaceuticals Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 151. Hansoh Pharmaceuticals Recent Development
Table 152. Kelun Pharmaceuticals Company Details
Table 153. Kelun Pharmaceuticals Business Overview
Table 154. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product
Table 155. Kelun Pharmaceuticals Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 156. Kelun Pharmaceuticals Recent Development
Table 157. Zai Lab Company Details
Table 158. Zai Lab Business Overview
Table 159. Zai Lab Gastrointestinal Stromal Tumor Treatment Product
Table 160. Zai Lab Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 161. Zai Lab Recent Development
Table 162. CStone Pharmaceuticals Company Details
Table 163. CStone Pharmaceuticals Business Overview
Table 164. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product
Table 165. CStone Pharmaceuticals Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 166. CStone Pharmaceuticals Recent Development
Table 167. China Biopharmaceuticals Company Details
Table 168. China Biopharmaceuticals Business Overview
Table 169. China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Product
Table 170. China Biopharmaceuticals Revenue in Gastrointestinal Stromal Tumor Treatment Business (US$ Million), 2021–2026
Table 171. China Biopharmaceuticals Recent Development
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
Table 175. Authors List of This Report


List of Figures
Figure 1. Gastrointestinal Stromal Tumor Treatment Picture
Figure 2. Global Gastrointestinal Stromal Tumor Treatment Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Gastrointestinal Stromal Tumor Treatment Market Share by Type: 2025 vs 2032
Figure 4. Drugs Features
Figure 5. Surgery Equipment Features
Figure 6. Others Features
Figure 7. Global Gastrointestinal Stromal Tumor Treatment Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Gastrointestinal Stromal Tumor Treatment Market Share by Application: 2025 vs 2032
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Pharmacy Case Studies
Figure 12. Others Case Studies
Figure 13. Gastrointestinal Stromal Tumor Treatment Report Years Considered
Figure 14. Global Gastrointestinal Stromal Tumor Treatment Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Gastrointestinal Stromal Tumor Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Gastrointestinal Stromal Tumor Treatment Market Share by Region: 2025 vs 2032
Figure 17. Global Gastrointestinal Stromal Tumor Treatment Market Share by Players in 2025
Figure 18. Global Gastrointestinal Stromal Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumor Treatment Revenue in 2025
Figure 20. North America Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Gastrointestinal Stromal Tumor Treatment Market Share by Country (2021–2032)
Figure 22. United States Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Gastrointestinal Stromal Tumor Treatment Market Share by Country (2021–2032)
Figure 26. Germany Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Market Share by Region (2021–2032)
Figure 34. China Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Gastrointestinal Stromal Tumor Treatment Market Share by Country (2021–2032)
Figure 42. Mexico Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Share by Country (2021–2032)
Figure 46. Israel Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Gastrointestinal Stromal Tumor Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. B. Braun Melsungen Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 50. Aohua Endoscopy Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 51. Olympus Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 52. Novartis Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 53. Bayer Pharmaceuticals Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 54. Glenmark Pharmaceuticals Ltd. Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 55. Fortimedix Surgical Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 56. Cook Medical Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 57. Actavis Generics Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 58. Dr. Reddy's Laboratories Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 59. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 60. Sonoscape Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 61. Huger endoscopy instruments Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 62. Bulat Pharmaceutical Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 63. MSN Laboratories Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 64. Apotex Inc. Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 65. Boston Scientific Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 66. Arthrex Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 67. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 68. CSPC Pharmaceuticals Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 69. Hansoh Pharmaceuticals Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 70. Kelun Pharmaceuticals Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 71. Zai Lab Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 72. CStone Pharmaceuticals Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 73. China Biopharmaceuticals Revenue Growth Rate in Gastrointestinal Stromal Tumor Treatment Business (2021–2026)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit